BioHarvest Sciences Debt to Equity Ratio 2020-2024 | BHST
Current and historical debt to equity ratio values for BioHarvest Sciences (BHST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. BioHarvest Sciences debt/equity for the three months ending June 30, 2024 was 0.00.
| BioHarvest Sciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$0.02B |
$0.01B |
3.03 |
| 2024-03-31 |
$0.02B |
$-0.00B |
-5.06 |
| 2023-12-31 |
$0.03B |
$-0.02B |
-2.01 |
| 2023-09-30 |
$0.02B |
$-0.01B |
-2.37 |
| 2023-06-30 |
$0.02B |
$-0.01B |
-2.71 |
| 2023-03-31 |
$0.01B |
$-0.01B |
-2.64 |
| 2022-12-31 |
$0.02B |
$-0.01B |
-2.58 |
| 2022-09-30 |
$0.01B |
$-0.00B |
-3.71 |
| 2022-06-30 |
$0.01B |
$-0.00B |
-12.85 |
| 2022-03-31 |
$0.01B |
$0.00B |
5.11 |
| 2021-12-31 |
$0.01B |
$0.00B |
2.58 |
| 2021-09-30 |
$0.01B |
$0.00B |
2.21 |
| 2021-06-30 |
$0.01B |
$0.00B |
595.79 |
| 2021-03-31 |
$0.01B |
$-0.00B |
-4.54 |
| 2020-12-31 |
$0.01B |
$-0.00B |
-3.31 |
| 2020-09-30 |
$0.00B |
$0.00B |
-27.71 |
| 2020-06-30 |
$0.01B |
$-0.00B |
-2.79 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-03-31 |
$0.00B |
$0.00B |
0.51 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
